share_log

B of A Securities Reinstates Neutral on AbbVie, Announces $191 Price Target

Benzinga ·  Dec 10, 2024 06:37  · Ratings

B of A Securities analyst Tim Anderson reinstates AbbVie (NYSE:ABBV) with a Neutral and announces $191 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment